Wang Cong, Shen Yamei, Zhang Yuxia, Guo Fahui, Li Qian, Zhang Huahua, Han Xueping, Zhao Haitao, Yang Zilong
Department of Hematology, Wuwei Tumor Hospital, Wuwei, China.
Wuwei Institute of Hematology, Wuwei, China.
Front Oncol. 2022 Jun 8;12:893319. doi: 10.3389/fonc.2022.893319. eCollection 2022.
The co-occurrence of multiple primary cancers with hematological malignancies is uncommon, and acute promyelocytic leukemia (APL) with MPC is even rarer, with only a few cases reported in the literature. Herein, we introduce the diagnosis and treatment of 2 cases of MPC complicated with APL in our hospital and review the relevant literature. Both patients were primary solid tumor patients and were treated with surgery and chemotherapy, and had stable disease (SD). However, more than 1 year after the primary tumor was diagnosed, clinical symptoms were found and APL was diagnosed. Both patients received standard remission-induction therapy, but unfortunately died in the short term due to hemorrhagic complications. In conclusion, treatment of hematological neoplasms, especially acute leukemia combined with multiple primary cancers, is challenging. The prognostic factors and survival analysis of MPC patients with combined APL still need further clinical research and analysis.
多种原发性癌症与血液系统恶性肿瘤同时发生的情况并不常见,而急性早幼粒细胞白血病(APL)合并多种原发性癌症则更为罕见,文献中仅报道了少数病例。在此,我们介绍我院2例MPC合并APL的诊断和治疗情况,并复习相关文献。两名患者均为原发性实体瘤患者,接受了手术和化疗,病情稳定(SD)。然而,在原发性肿瘤确诊1年多后,出现临床症状并被诊断为APL。两名患者均接受了标准的诱导缓解治疗,但不幸的是,均因出血并发症在短期内死亡。总之,血液系统肿瘤的治疗,尤其是急性白血病合并多种原发性癌症的治疗具有挑战性。MPC合并APL患者的预后因素和生存分析仍需进一步的临床研究和分析。